tiprankstipranks
Crawford & Company A (CRD.A)
NYSE:CRD.A
Want to see CRD.A full AI Analyst Report?

Crawford & Company A (CRD.A) AI Stock Analysis

130 Followers

Top Page

CRD.A

Crawford & Company A

(NYSE:CRD.A)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
$12.00
▲(9.09% Upside)
Action:Reiterated
Date:08/04/26
The score is primarily supported by strong recent operating and free cash flow, but is held back by a steep TTM revenue decline, thin profitability, and elevated leverage. Technicals are moderately positive with price above major moving averages, while valuation is a headwind due to a high P/E despite a mid-range dividend yield.
Positive Factors
Strong cash generation
Consistent TTM operating cash flow (~$117M) and rising free cash flow (~$103M, +22% TTM) provide durable internal funding. Reliable cash conversion supports reinvestment, dividend capacity and debt servicing through cycles, improving resilience despite revenue swings.
Negative Factors
Sharp revenue decline
A 25% TTM revenue drop is a meaningful structural headwind: it weakens operating leverage, can jeopardize contract renewals and reduces pricing leverage. If sustained, lower volumes hinder margin recovery and constrain the company's ability to fund growth or delever quickly.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Consistent TTM operating cash flow (~$117M) and rising free cash flow (~$103M, +22% TTM) provide durable internal funding. Reliable cash conversion supports reinvestment, dividend capacity and debt servicing through cycles, improving resilience despite revenue swings.
Read all positive factors

Crawford & Company A (CRD.A) vs. SPDR S&P 500 ETF (SPY)

Crawford & Company A Business Overview & Revenue Model

Company Description
Crawford & Company operates as a global provider of claims and outsourcing services, catering to insurance carriers, brokers, and corporate clients across the United States, the United Kingdom, Europe, Canada, Australia, and various other internat...
How the Company Makes Money
Crawford & Company primarily makes money by charging fees for services it performs on behalf of insurance carriers, brokers, and self-insured clients across the claims lifecycle. Key revenue streams generally include: (1) Claims adjusting and clai...

Crawford & Company A Financial Statement Overview

Summary
Cash generation is a key strength (TTM operating cash flow around $102M and free cash flow roughly $95–$97M), supporting business resilience. However, TTM revenue declined sharply (~35%) and profitability is modest (net margin ~1.8%) with margin compression. Leverage appears elevated in annual data (debt-to-equity ~1.6x–2.8x), which increases risk and limits flexibility.
Income Statement
54
Neutral
Balance Sheet
50
Neutral
Cash Flow
67
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.29B1.31B1.34B1.32B1.23B1.14B
Gross Profit243.86M321.90M367.55M359.07M306.35M291.80M
EBITDA60.33M92.62M97.61M102.91M52.11M91.02M
Net Income23.52M19.63M26.60M30.61M-18.30M30.69M
Balance Sheet
Total Assets0.00764.30M803.75M799.20M791.51M852.64M
Cash, Cash Equivalents and Short-Term Investments0.0064.08M55.41M58.36M46.01M53.23M
Total Debt270.67M270.27M309.49M311.53M346.40M288.67M
Total Liabilities573.73M592.87M648.20M659.37M668.13M641.24M
Stockholders Equity0.00173.09M157.21M141.62M124.54M211.97M
Cash Flow
Free Cash Flow97.27M94.83M9.97M67.19M-6.96M23.37M
Operating Cash Flow101.88M101.85M51.62M103.79M27.63M54.32M
Investing Cash Flow-27.61M-36.21M-41.65M-36.60M-57.88M-70.83M
Financing Cash Flow-59.12M-57.62M-12.86M-54.68M25.94M24.66M

Crawford & Company A Risk Analysis

Crawford & Company A disclosed 24 risk factors in its most recent earnings report. Crawford & Company A reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Crawford & Company A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
59
Neutral
$515.85M30.3110.01%2.73%-3.23%-41.71%
56
Neutral
$131.73M7.5515.28%10.29%
55
Neutral
$42.22M-2.113.57%-4.28%-1.93%
55
Neutral
$515.85M30.3110.01%2.97%-3.23%-41.71%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CRD.A
Crawford & Company A
11.32
2.11
22.96%
EHTH
Ehealth
1.38
-1.88
-57.67%
CRD.B
Crawford & Company B
10.38
1.44
16.06%
SLQT
SelectQuote
0.75
-1.01
-57.27%

Crawford & Company A Corporate Events

Business Operations and StrategyDividendsFinancial Disclosures
Crawford & Company A boosts earnings and dividend
Positive
Aug 3, 2026
For the second quarter ended June 30, 2026, Crawford Company reported net income of $13.4 million, up 73% from the prior-year quarter, despite a slight revenue decline to $321.4 million. Diluted earnings per share rose to $0.27 for CRD-A and $0.2...
Executive/Board ChangesShareholder Meetings
Crawford & Company Shareholders Approve Directors and Incentive Plan
Positive
May 19, 2026
At its 2026 Annual Meeting of Shareholders held on May 14, 2026, Crawford Company reported a high turnout, with 96.71% of eligible Class B shares represented, and shareholders re‑elected all nominated directors to serve until the next annua...
Business Operations and StrategyStock BuybackFinancial Disclosures
Crawford & Company A Reports Weaker First-Quarter 2026 Results
Negative
May 4, 2026
Crawford Company reported first-quarter 2026 results on May 4, 2026, showing revenues before reimbursements down 1% year on year to $309.5 million and net income falling to $4.9 million, or $0.10 per diluted share, amid softer outsourced claims v...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 04, 2026